Tech Center 1600 • Art Units: 1600 1625 1628
This examiner grants 100% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18575739 | METHODS AND COMPOSITIONS FOR TREATMENT OF COVID-19 | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18363207 | NLRP3 INFLAMMASOME INHIBITORS | Non-Final OA | Novartis AG |
| 18364112 | METHODS FOR TREATING CANCER | Non-Final OA | Washington University |
| 18285381 | METHODS AND COMPOUNDS OF CANNABIDIOL, MELATONIN AND AKBA FOR TREATING PANCREATIC CANCER | Non-Final OA | FONDAZIONE MARIA GUARINO AMOR ONLUS |
| 18350099 | 3,5-DIIODOTHYROPROPIONIC ACID COMPOSITIONS AND METHODS OF USE THEREOF | Non-Final OA | DEXCEL PHARMA TECHNOLOGIES LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy